Implantable Medical Devices Market Size to Hit Around USD 145.6 Billion by 2030

Published Date : 08 Sep 2022

The global implantable medical devices market size is projected to hit around USD 145.6 billion by 2030 and expanding growth at a CAGR of 7% over the forecast period 2022 to 2030.

According to the United Nations, there were around 382 million old age people, aged 60 years or above, across the globe in 2017 and this number is expected 2.1 billion by 2050. The old age people are prone to various chronic diseases such as cardiovascular diseases, endovascular diseases, orthopedic disorders, and dental disorders, which can foster the demand for the implantable medical devices across the globe. 

The global implantable medical devices market is driven by the rising demand for replacement or support of the bones, joints or other body tissues, owing to the rising prevalence of chronic diseases, rising cases of accidents, and trauma. The technological advancements in the healthcare industry has enabled the people to improve their looks and enhance their aesthetic beauty by using implantable medical devices such as dental implants, breast implants, pectoral implants, deltoid implants, and cochlear implants.

Regional Snapshot

North America dominated the global implantable medical devices market in 2021. The increased prevalence of various chronic diseases and increasing geriatric population in the region is a significant driver of the implantable medical devices market. Further, the developed healthcare infrastructure in the region and rising popularity of the minimally invasive surgeries is anticipated to boost the market growth. Further, the increased awareness regarding the various implants has positively contributed towards the growth of the market in North America.According to the CDC, approximately 64% of the US population of age between 18 years to 64 years, visited clinics related to their medical health in 2017. Hence, the rising number of clinical visits in US is another driving force may contribute towards the market growth.

Asia Pacific is estimated to be the fastest-growing market during the forecast period. The rising government expenditure in region for the development of advanced healthcare infrastructure in fueling the market growth. Moreover rising number of road accidents may drive the demand for implantable medical devices. According to the WHO, around 93% of the road traffic accident cases are recorded in the low and middle income countries. Moreover, the growing geriatric population in the region is another significant factor that is expected to drive the market growth in the upcoming future. According to the United Nations, around 80% of the global geriatric population is expected to be living in the low and middle income nations.

Scope of the Report

Report Coverage Details
Market Size in 2021 USD 90.5 Billion
Revenue Forecast by 2030 USD 145.6 Billion
Growth Rate CAGR of 7% from 2022 to 2030
By Product
  • Cardiovascular Implants
  • Orthopedic Implants
  • Intraocular Lens
  • Spinal Implants
  • Dental Implants
  • Others
By Material
  • Ceramic
  • Metallic
  • Polymers
  • Natural
By Region
  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • MEA

 

Market Dynamics

Driver

Rising demand for the minimally invasive surgeries

Minimally invasive surgeries are being performed for numerous health conditions such as degenerative spinal disorders, fractures, knee trauma, herniated discs, stenosis, and others. These type of surgeries may foster the usage of implantable medical devices and expected to drive the market growth in the forthcoming years.

Restraints

Lack of skilled surgeons

There is an acute shortage of skilled and experienced surgeon in the low and middle income countries. As per the data published by the Lancet Commission on Global Surgery, more than 2 million surgeons are require in the middle and low income nation every year. Therefore, the lack of the skilled surgeons may restrict the adoption of the implantable medical devices and may hinder the market growth.

Opportunities

Rising number of surgical centers and hospitals across the globe

The growing investments by the corporate sector and the government in the development of the hospitals especially in the developing and underdeveloped regions is expected to offer lucrative growth opportunities to the market players. The rising number of hospitals and surgical centers across the globe is expected to drive the adoption of the implantable medical devices in the foreseeable future.

Challenges

Lack of awareness among the people

There is a lack of awareness among the population regarding the availability of technologically advanced implantable medical devices. Spreading awareness among the people in the developing and underdeveloped countries is anticipated to be a major challenge for the market players.

Report Highlights

  • Based on product type, the orthopedic implants segment dominated the market in 2021. This is attributed to the growing geriatric population and increased number of orthopedic surgeries. The old age population are the major adopters of the implantable medical devices owing to the increased demand for the orthopedic surgeries among them. According to the Australia Bureau of Statistics, around 458,000 people have rheumatoid arthritis by 2018. Hence, the surging number of rheumatoid arthritis is augmenting the market growth.
  • Based on the biomaterial, the metallic segment dominated the market in 2021. This can be attributed to the rising number of minimally invasive surgeries. The metallic devices are extensively used for supporting broken joints across the globe. Further, rising road accidents that leads to the fracture in bones and joints is expected to drive the market growth.

Some of the prominent players:

  • Abbott Laboratories
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • C. R. Bard, Inc.
  • Cardinal Health, Inc.
  • CONMED Corporation
  • Globus Medical, Inc.
  • Integra Lifesciences Holdings Corporation
  • Johnson & Johnson
  • LivaNova PLC
  • Medtronic plc
  • NuVasive, Inc.
  • Smith & Nephew plc
  • St. Jude Medical, Inc.
  • InstitutStraumann AG

Full Report is Ready | Buy this Research Report@ https://www.precedenceresearch.com/checkout/1430

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 9197 992 333